Indian-American to lead FDA |
Indian-American Balaji S Srinivasan, a successful Silicon Valley-based entrepreneur and CEO of a bitcoin startup, is under consideration for Trump administration`s pick to lead the Federal Drug Administration (FDA) after he met the US President-elect. The incoming White House Press Secretary Sean Spicer although confirmed that Balaji is under consideration for the position of heading FDA, the all-important federal agency for drug and pharma industry. Srinivasan, along with Jim O`Neill, managing director of Mithril Capital Management, is being considered for position in the FDA, Spicer said. Spicer said Srinivasan currently serves as the CEO and cofounder of 21.co and is a partner in Andreessen Horowitz. He has won FDA approval as a genomics entrepreneurial. He is broadly interested in new technology, with a particular focus on "real world" applications where digital bits interface with physical atoms and substantive problems, such as quantified self (healthcare), MOOCs/edtech (education), Bitcoin (finance), drones, and 3D printing. He has also been a lecturer at Departments of Statistics, and Computer Science at the prestigious Stanford University. Balaji describes himself as a computer scientist, investor, entrepreneur, and academic. He holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford.
|
|